Wang et al. [30] observed overexpression of cyclin D1 in prostate adenocarcinoma, while the research team led by Yin [31] reported reduced expression of this protein in prostate cancer, highlighting the heterogeneous nature of cyclin D1 regulation in prostate cancer progression. Here, CCND1 is linked to prostate adenocarcinoma.